In one of their periodic quizzes to test clinician knowledge, Medscape reinterates that caffeine consumption is associated with a LOWER risk of development of Parkinson’s Disease.

A relationship between increased caffeine intake and lower risk for Parkinson’s disease has been repeatedly confirmed. A more recent study that specifically focused on the effects of caffeine in individuals with a mutation in the leucine-rich repeat kinase 2 (LRRK2) gene found that that group in particular may benefit from caffeine-related therapies.

Windle, Medscape

Yes, caffeine as a “therapy.”

Further, coffee consumption benefits patients with chronic liver disease.

A systematic review found that patients with chronic liver disease who consume coffee have a decreased risk for progression to cirrhosis, a lower mortality rate, and a lower rate of hepatocellular carcinoma development.

Medscape

A combination of acetylsalicylic acid (aspirin), acetaminophen, and caffeine is approved in the US as a safe and effective treatment…